TL42: What do we do when the Sites are not Poolable?
*Jack Zhou, FDA CDRH
For multicenter clinical trials, one way to demonstrate poolability is to test the treatment-by-site interactions. A large p-value from this test would indicate a consistent treatment effect between sites. However, what happens if a small p-value is shown for the treatment-by-site interaction test and the sites are not poolable? Any further analyses can be done besides stratifying the results by site? Please come share your opinions and stories.
April 30 - May 22, 2013
Invited Abstract Submission Open
June 4, 2013
Online Registration Opens
August 9 - August 23, 2013
Invited Abstract Editing
August 23, 2013
Short Course materials due from Instructors
August 26, 2013
September 9, 2013
Cancellation Deadline and Registration Closes @ 11:59 pm EDT
September 16 - September 18, 2013
Marriott Wardman Park, Washington, DC